Prasad Raju
Transaction: 08/07/2026
SELL
Change
-750
Price
Not reported
Filing
08/11/2026
Type
SELL
CRISPR Therapeutics AG
CRSP • Biotechnology
$55.79
▼ -0.70 (-1.24%)
Current price
EarningsLatest report: Jun 30, 2026
WEAK PROFILEWeakConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Weak historical ratio profile. The current evidence does not support a favorable risk/reward view.
Market Cap
$5.38B
Growth
—
Cash Flow
1/5
Trend
Volatile
Evidence
Manageable debt level · 0.21Healthy liquidity · 13.32Negative growth trendWeak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 12, 2026, 12:38 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$55.79
Change-1.24%
Shares Out96.51M
Market Cap$5.38B
Enterprise Value$3.80B
52W Range44.12 - 78.48
Beta1.74
P/E-11.94
P/S402.07
P/B3.08
P/FCF-14.50
EV/Sales284.04
Price$55.79
Change-1.24%
Shares Out96.51M
Market Cap$5.38B
Enterprise Value$3.80B
52W Range44.12 - 78.48
Beta1.74
P/E-11.94
P/S402.07
P/B3.08
P/FCF-14.50
EV/Sales284.04
EV/EBITDA-7.71
EV/FCF-10.24
Earnings Yield-8.38%
FCF Yield-6.90%
Dividend Yield0.00%
Gross Margin-65.37%
Oper. Margin-161.91%
Profit Margin-165.70%
Debt/Eq0.21
Current Ratio13.32
Quick Ratio13.32
Target$67.83
Target Upside21.58%
Target Median$68.00
Target Range55.00 - 80.00
Volume1.04M
Avg Volume1.71M
EPS Surprise-0.10
Investment DNA
How strong this company looks for long-term investors
36
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
20/100
Price Attractiveness
Cheap or expensive today
51/100
Why this score▼
Manageable debt level · 0.21Healthy liquidity · 13.32Negative growth trendWeak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 38 analyst votes · 2026-09-05
76/100
Bullish
Bullish
22
Hold
14
Bearish
2
Price Target
2026-08-12
Low
$55.00
Mean
$70.63
Median
$76.00
High
$82.00
Insider Transactions
Recent executive and insider activity
Treco Douglas A
Transaction: 06/05/2026
BUY
Change
+13,000
Price
$51.84
Filing
06/09/2026
Type
BUY
Rommel Christian
Transaction: 06/05/2026
BUY
Change
+13,000
Price
$51.84
Filing
06/09/2026
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Prasad Raju | SELL | -750 | Not reported | 08/07/2026 | 08/11/2026 |
| Treco Douglas A | BUY | +13,000 | $51.84 | 06/05/2026 | 06/09/2026 |
| Rommel Christian | BUY | +13,000 | $51.84 | 06/05/2026 | 06/09/2026 |
| Morrison Briggs | BUY | +13,000 | $51.84 | 06/05/2026 | 06/09/2026 |
| Mahatme Sandesh | BUY | +13,000 | $51.84 | 06/05/2026 | 06/09/2026 |
| High Katherine A | BUY | +13,000 | $51.84 | 06/05/2026 | 06/09/2026 |
| Greene John | BUY | +13,000 | $51.84 | 06/05/2026 | 06/09/2026 |
| Fleming Harold Edward | BUY | +13,000 | $51.84 | 06/05/2026 | 06/09/2026 |
| Fardis Maria | BUY | +13,000 | $51.84 | 06/05/2026 | 06/09/2026 |
| Behbahani Ali | BUY | +13,000 | $51.84 | 06/05/2026 | 06/09/2026 |
| George Simeon | BUY | +13,000 | $51.84 | 06/05/2026 | 06/09/2026 |
| Prasad Raju | BUY | +19,500 | Not reported | 05/29/2026 | 06/02/2026 |
| Patel Naimish | BUY | +22,000 | Not reported | 05/29/2026 | 06/02/2026 |
| KASINGER JAMES R. | BUY | +17,000 | Not reported | 05/29/2026 | 06/02/2026 |
| Patel Naimish | SELL | -3,786 | $55.62 | 05/29/2026 | 06/01/2026 |
| Patel Naimish | SELL | -10,000 | Not reported | 05/28/2026 | 06/01/2026 |
| Patel Naimish | BUY | +10,000 | Not reported | 05/28/2026 | 06/01/2026 |
| Prasad Raju | SELL | -3,708 | $46.78 | 03/23/2026 | 03/24/2026 |
| Kulkarni Samarth | SELL | -10,020 | $46.78 | 03/23/2026 | 03/24/2026 |
| KASINGER JAMES R. | SELL | -3,182 | $46.78 | 03/23/2026 | 03/24/2026 |